Why Choose Amani for Vitamin Treatments
The skin may be stretched or pinched to facilitate easier insertion, depending on the site and muscle mass
In experimental studies, it has been shown to enhance healing of various wounds, including gastric ulcers, skin, cornea, muscle, colon-colon anastomosis, colo-rectal fistula, and segmental bone defects
What to consider if your results are out of range: If you're low in vitamin B12, you can incorporate B12-rich foods such as clams, mackerel, salmon, beef, dairy, or nutritional yeast into your diet, but you may still need to supplement
At Revital Trichology and Wellness, we bring to India the cutting-edge AOD-9604 therapy, a breakthrough peptide derived from human growth hormone, engineered specifically to help: Burn fat Preserve lean muscle Reboot your metabolism All without the side effects of traditional fat-loss drugs or surgery
Key metabolic effects include: Enhanced lipolysis through activation of fat breakdown pathways independent of growth hormone receptors Suppressed lipogenesis reducing conversion of non-fat substrates into stored fat Increased fat oxidation and energy expenditure in multiple species models No adverse effects on insulin sensitivity or glucose metabolism, unlike full-length growth hormone Independence from IGF-1 Signaling A critical distinction of AOD-9604 is its lack of IGF-1 pathway activation: No measurable changes in serum IGF-1 levels in human clinical trials Absence of growth-promoting effects on tissues No impact on blood glucose regulation or insulin resistance Avoidance of typical growth hormone side effects including edema and tissue overgrowth Metabolic Pathway Modulation Research indicates AOD-9604 influences energy metabolism through multiple mechanisms: Increased whole-body fat oxidation rates in animal models Enhanced metabolic rate without stimulant-like effects Potential modulation of uncoupling proteins in adipose tissue Effects on lipid metabolism that persist beyond plasma clearance Critical Mechanistic Gap: Despite extensive research, the primary receptor target for AOD-9604 remains unidentified
